It would pay to keep in mind that the BOT management have...

It would pay to keep in mind that the BOT management have strategically decided in their business plan to develop their products via the clinical process which means time - with a better chance of a massive payoff.

It is not a cosmetic. The market where every man and his dog puts a cream in a jar, fancy label and then adds a pack of lies with fancy marketing about turning your wrinkles into peaches and cream. Usually then repackaged under a different label with another celebrity to carry on the misleading story. Amusing really.

The products that BOT are producing are game changing in a market where the existing stakeholders have not had competition for years. "They" will be taking note as BOT are now well down the track with the relevant clinic trials - the business plan remains on track and much to unfold.